PENNUTO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.216
AS - Asia 3.212
EU - Europa 2.122
AF - Africa 832
SA - Sud America 718
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 49
Totale 13.230
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.776
SG - Singapore 1.135
IT - Italia 607
CN - Cina 565
BR - Brasile 431
HK - Hong Kong 428
VN - Vietnam 232
DE - Germania 167
PL - Polonia 123
FI - Finlandia 118
GB - Regno Unito 89
NL - Olanda 86
RU - Federazione Russa 82
SE - Svezia 70
FR - Francia 65
MX - Messico 64
AR - Argentina 58
BJ - Benin 54
ES - Italia 50
KR - Corea 49
ZA - Sudafrica 49
TR - Turchia 44
AT - Austria 42
IQ - Iraq 41
UA - Ucraina 40
EC - Ecuador 39
IN - India 38
JP - Giappone 35
ID - Indonesia 34
JO - Giordania 34
IE - Irlanda 33
AE - Emirati Arabi Uniti 32
AM - Armenia 32
MA - Marocco 31
CI - Costa d'Avorio 30
MK - Macedonia 30
SI - Slovenia 30
AO - Angola 29
BA - Bosnia-Erzegovina 29
CO - Colombia 29
SA - Arabia Saudita 29
BE - Belgio 28
CA - Canada 28
KG - Kirghizistan 28
VE - Venezuela 28
HN - Honduras 27
TT - Trinidad e Tobago 27
XK - ???statistics.table.value.countryCode.XK??? 27
GH - Ghana 26
NO - Norvegia 26
PR - Porto Rico 26
RS - Serbia 26
TJ - Tagikistan 26
UZ - Uzbekistan 26
AZ - Azerbaigian 25
LU - Lussemburgo 25
ML - Mali 25
MN - Mongolia 25
SO - Somalia 25
GA - Gabon 24
GR - Grecia 24
KE - Kenya 24
UY - Uruguay 24
BB - Barbados 23
BD - Bangladesh 23
BO - Bolivia 23
BY - Bielorussia 23
CL - Cile 23
CV - Capo Verde 23
HU - Ungheria 23
JM - Giamaica 23
NP - Nepal 23
PK - Pakistan 23
PY - Paraguay 23
TZ - Tanzania 23
CW - ???statistics.table.value.countryCode.CW??? 22
DK - Danimarca 22
LA - Repubblica Popolare Democratica del Laos 22
LV - Lettonia 22
LY - Libia 22
ME - Montenegro 22
MR - Mauritania 22
PS - Palestinian Territory 22
SK - Slovacchia (Repubblica Slovacca) 22
TH - Thailandia 22
CG - Congo 21
CR - Costa Rica 21
CZ - Repubblica Ceca 21
DZ - Algeria 21
EG - Egitto 21
KZ - Kazakistan 21
LB - Libano 21
NG - Nigeria 21
YT - Mayotte 21
BZ - Belize 20
CH - Svizzera 20
CY - Cipro 20
ET - Etiopia 20
GF - Guiana Francese 20
GT - Guatemala 20
Totale 12.354
Salva come PNG Salva come JPEG
Città #
Fairfield 1.068
Ashburn 758
Singapore 578
Woodbridge 428
Hong Kong 399
Houston 387
Seattle 360
Cambridge 339
Wilmington 263
Chandler 254
Beijing 213
Ann Arbor 187
Santa Clara 127
Padova 126
Boardman 116
San Diego 114
Padua 90
Bytom 81
Princeton 78
Medford 74
New York 72
Los Angeles 66
Ho Chi Minh City 64
Munich 62
Dong Ket 61
Cotonou 54
Helsinki 51
Des Moines 47
Roxbury 45
Chicago 44
Hefei 44
Milan 42
São Paulo 36
Amman 33
Hanoi 33
Seoul 31
Nanjing 30
Abidjan 29
London 28
Yerevan 28
Bishkek 27
Baku 25
Dushanbe 25
Ulan Bator 25
Bamako 24
Nuremberg 24
Rome 24
Tokyo 24
Turku 24
Vienna 24
Bridgetown 23
Dublin 23
Libreville 23
Vicenza 23
Warsaw 23
Accra 22
Johannesburg 22
Lappeenranta 22
Nairobi 21
Vientiane 21
Buffalo 20
Castries 20
Denver 20
Luanda 20
Managua 20
Nouakchott 20
Tashkent 20
Andorra la Vella 19
Dakar 19
Dar es Salaam 19
Phoenix 19
Praia 19
Riga 19
Amsterdam 18
Brooklyn 18
Lusaka 18
Montevideo 18
Podgorica 18
Willemstad 18
Addis Ababa 17
Baghdad 17
Frankfurt am Main 17
Kampala 17
La Paz 17
Ljubljana 17
Minsk 17
Phnom Penh 17
Stockholm 17
Washington 17
Brazzaville 16
Kingstown 16
Mamoudzou 16
Mexico City 16
Pristina 16
Quito 16
Boston 15
Kingston 15
Panama City 15
San José 15
Banjul 14
Totale 8.111
Salva come PNG Salva come JPEG
Nome #
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 290
271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands 269
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 263
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 255
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet 250
210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands 235
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 231
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 214
Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy 208
Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy 192
Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function 187
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 180
Insights into the genetic epidemiology of SBMA: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. 180
The role of AR polyQ tract in male breast carcinoma: lesson from an SBMA case 176
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease 173
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. 170
Protein Arginine Methyltransferase 6 Enhances Polyglutamine-Expanded Androgen Receptor Function and Toxicity in Spinal and Bulbar Muscular Atrophy 170
Pathogenesis of Polyglutamine Diseases 167
Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis 159
Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle 157
Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease 157
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA) 156
Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes 155
Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy 154
Motor Neuron Diseases and Neuroprotective Peptides: A Closer Look to Neurons 154
Altered ionic currents and amelioration by IGF-1 and PACAP in motoneuron-derived cells modelling SBMA 151
Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease) 149
The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel-Lindau tumor suppressor 149
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice 147
Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity 147
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome 145
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 144
Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice 144
B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy 144
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis 140
Taipoxin induces synaptic vesicle exocytosis and disrupts the interaction of synaptophysin I with VAMP2 139
ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease 139
Huntingtin-mediated axonal transport requires arginine methylation by PRMT6 139
Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients 137
Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency 134
Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice 133
Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization 133
Neurotoxic effects of androgens in spinal and bulbar muscular atrophy 130
Post-translational modifications of expanded polyglutamine proteins: Impact on neurotoxicity 129
Snake presynaptic neurotoxins with phospholipase A2 activity induce swelling of synaptic boutons and exoxytosis of synaptic vesicles 125
Fluorescence resonance energy transfer detection of synaptophysin I and vesicle-associated membrane protein 2 interactions during exocytosis from single live synapses 124
The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2B 124
Differential autophagy power in the spinal cord and muscle of transgenic ALS mice 124
Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice 124
New routes to therapy for spinal and bulbar muscular atrophy 119
Interplay of the E box, the cyclic AMP response element, and HTF4/HEB in transcriptional regulation of the neurospecific, neurotrophin-inducible vgf gene 119
Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy 118
Pharmacological inactivation of the prion protein by targeting a folding intermediate 118
The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA) 117
Neurite extension occurs in the absence of regulated exocytosis in PC12 subclones 117
Synaptophysin I Controls the Targeting of VAMP2/Synaptobrevin II to Synaptic Vesicles 117
Insulin-like growth factor 1 signaling in motor neuron and polyglutamine diseases: From molecular pathogenesis to therapeutic perspectives 117
Catechol-O-methyl transferase modulates cognition in late life: Evidence and implications for cognitive enhancement 116
AR cooperates with SMAD4 to maintain skeletal muscle homeostasis 115
Clarifying main nutritional aspects and resting energy expenditure in children with Smith-Magenis syndrome 115
From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet? 114
NURR1 and ERR1 modulate the expression of genes of a DRD2 co-expression network enriched for schizophrenia risk 113
Introduction to the Special Issue “Skeletal Muscle Atrophy: Mechanisms at a Cellular Level” 112
Induced pluripotent stem cells for modeling Smith-Magenis syndrome 112
Protein Arginine Methyltransferase 1 and 8 Interact with FUS to Modify Its Sub-Cellular Distribution and Toxicity In Vitro and In Vivo 112
In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy 112
Mutations in TGM6 induce the unfolded protein response in SCA35 111
Pituitary Adenylyl Cyclase Activating Polypeptide (PACAP) Signaling and the Cell Cycle Machinery in Neurodegenerative Diseases 110
Synaptophysin: Leading actor or walk-on role in synaptic vesicle exocytosis? 109
241st ENMC international workshop: Towards a European unifying lab for Kennedy's disease. 15-17th February, 2019 Hoofddorp, The Netherlands 109
Rescue of Metabolic Alterations in AR113Q Skeletal Muscle by Peripheral Androgen Receptor Gene Silencing 108
Mitochondrial abnormalities in spinal and bulbar muscular atrophy 107
The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer 106
Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases 105
Identification and Expression of Acetylcholinesterase in Octopus vulgaris Arm Development and Regeneration: a Conserved Role for ACHE? 104
Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and Aβ1–42-mediated toxicity 104
Post-translational modifications and protein quality control in motor neuron and polyglutamine diseases 103
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A) 100
Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene 99
Serine phosphorylation and arginine methylation at the crossroads to neurodegeneration 99
Native functions of the androgen receptor are essential to pathogenesis in a drosophila model of spinobulbar muscular atrophy 98
Skeletal Muscle Pathogenesis in Polyglutamine Diseases 97
Increased SIRT3 combined with PARP inhibition rescues motor function of SBMA mice 96
Revisiting default mode network function in major depression: Evidence for disrupted subsystem connectivity 96
MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B 95
Editorial Comment to Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy 95
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region 94
Mutational screening of androgen receptor gene in 8224 men of infertile couples 93
Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy 91
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction 91
The evolution of eukaryotic linear motifs governing the function of androgen receptor from fish to Homo sapiens 88
Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy 87
Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene 86
Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy 82
Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle 79
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity 79
Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis 68
Behavioral inflexibility through overtraining is mediated by reduced mGluR1/5 signaling capacity in the dorsolateral striatum 65
Hearing Function in Spinal and Bulbar Muscular Atrophy (SBMA): A Case Control Study From a Tertiary Referral Center 61
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A 56
Totale 13.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.024
article - articoli 42.621
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 403
Totale 86.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021752 0 0 0 0 82 35 24 95 125 138 118 135
2021/20221.284 47 195 221 67 33 59 87 110 55 37 134 239
2022/2023657 119 68 10 62 100 73 10 85 77 4 31 18
2023/2024689 23 48 71 58 81 117 77 29 29 21 67 68
2024/20252.317 17 147 75 77 288 79 140 186 206 142 384 576
2025/20265.423 508 752 1.429 1.874 860 0 0 0 0 0 0 0
Totale 13.406